Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Israel Business Currents.
Press releases published on June 16, 2025
Nimble Goes Live with Unibeam, Delivering Seamless and Secure Authentication for Clients and Partners
EIN Presswire
·
June 16, 2025
TEL AVIV, ISRAEL, June 16, 2025 /EINPresswire.com/ -- Nimble, a supply‑chain finance fintech platform enabling businesses to offer early invoice payments and optimize working capital, today announced the selection of Unibeam’s authentication platform to …
Sela Cloud Achieves ISO 27001:2022 Certification
EIN Presswire
·
June 16, 2025
Sela Cloud Achieves ISO 27001:2022 Certification, Reinforcing Leadership in Secure Cloud Consulting for the AI Era PHILADELPHIA, PA, UNITED STATES, June 16, 2025 /EINPresswire.com/ -- Sela Cloud, a Premier Tier Partner for AWS, Google Cloud, and …
Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnering Meetings at the 2025 BIO International Convention in Boston
GlobeNewswire
·
June 16, 2025
Ramat Gan, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule drugs for the treatment of cancer and inflammatory …
SaverOne Signs Preliminary Agreement with Leading European ADAS Technology Provider for Sensor Fusion Collaboration
GlobeNewswire
·
June 16, 2025
This Collaboration Integrates SaverOne’s VRU Detection Solution into an ADAS Platform for Enhanced Road Safety Petah Tikvah, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology company engaged in innovative …
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology
GlobeNewswire
·
June 16, 2025
Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun Pharma-Teva collaboration agreement established with goal of accelerating clinical data generation for TEV- …